# Clinical Evaluation of Florbetapir F 18 (18F-AV-45)

> **NCT01518374** · PHASE2 · COMPLETED · sponsor: **Avid Radiopharmaceuticals** · enrollment: 1768 (actual)

## Conditions studied

- Alzheimer Disease
- Mild Cognitive Impairment
- Neurodegenerative Diseases

## Interventions

- **DRUG:** Florbetapir F 18

## Key facts

- **NCT ID:** NCT01518374
- **Lead sponsor:** Avid Radiopharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2017-05-03
- **Final completion:** 2017-05-03
- **Target enrollment:** 1768 (ACTUAL)
- **Last updated:** 2018-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01518374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01518374, "Clinical Evaluation of Florbetapir F 18 (18F-AV-45)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01518374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*